Efficacy and safety of once‐daily insulin degludec dosed flexibly at convenient times vs fixed dosing at the same time each day in a Japanese cohort with type 2 diabetes: A randomized, 26‐week, treat‐to‐target trial

AIMS/INTRODUCTION: This trial assessed the efficacy and safety of the possibility of varying the daily injection time of once‐daily, long‐acting basal insulin degludec (IDeg) in Japanese patients with type 2 diabetes inadequately controlled with insulin glargine. MATERIALS AND METHODS: This was a 26...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Takashi, Jinnouchi, Hideaki, Kaku, Kohei, Hersløv, Malene L, Hyllested‐Winge, Jacob, Nakamura, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009133/
https://www.ncbi.nlm.nih.gov/pubmed/27182031
http://dx.doi.org/10.1111/jdi.12502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009133/
https://www.ncbi.nlm.nih.gov/pubmed/27182031
http://dx.doi.org/10.1111/jdi.12502

Ejemplares similares